Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Xenotransplantation|February 8, 2005
Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factorChun-Yan Zhou, Elizabeth McInnes, Laura Copeman, et al.
Asia-Pacific Journal of Clinical Oncology|October 5, 2010
The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapyChristine Carrington, Leanne Stone, Bogda Koczwara, et al.
Asia-Pacific Journal of Clinical Oncology|January 31, 2022
A smartphone program to support adherence to oral chemotherapy in people with cancer: Proof-of-concept trialXiomara Skrabal Ross, Kate M Gunn, Vijayaprakash Suppiah, et al.
Plos One|September 28, 2017
Serological evidence of arenavirus circulation among fruit bats in TrinidadAshley Malmlov, Janine Seetahal, Christine Carrington, et al.
Xenotransplantation|May 2, 2002
Production and characterization of a pig line transgenic for human membrane cofactor proteinChun-Yan Zhou, Elizabeth McInnes, Nicola Parsons, et al.
Applied & Translational Genomics|August 25, 2016
Addressing ethical challenges in the Genetics Substudy of the National Eye Survey of Trinidad and Tobago (GSNESTT)Allana N Roach, Tasanee Braithwaite, Christine Carrington, et al.
Ophthalmic Epidemiology|January 21, 2017
The National Eye Survey of Trinidad and Tobago (NESTT): Rationale, Objectives and MethodologyTasanee Braithwaite, Neville Q Verlander, Debra Bartholomew, et al.
Scientific Reports|May 7, 2021
Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancersHye-Hyun Ahn, Christine Carrington, Yizong Hu, et al.
Trials|January 7, 2021
Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial)Raymond Javan Chan, Stephanie Buhagiar, Laisa Teleni, et al.
Trials|October 16, 2020
Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in breast cancer post-treatment follow-up: a study protocol for a phase II randomised controlled trial (the EMINENT trial)Raymond Javan Chan, Jon Emery, Katharine Cuff, et al.
Pageof 3